Navigation Links
Digestive Enzyme Supplements Market to Reach $1.6 Billion by 2025 - Growing Consumer Awareness Regarding the Severity of Digestive Disorders - Research and Markets
Date:2/28/2017

DUBLIN, Feb 28, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Digestive Enzyme Supplements Market Forecasts 2014-2025" report to their offering.

The global digestive enzyme supplements market is expected to reach USD 1.6 billion by 2025. Growing consumer awareness regarding the severity of digestive disorders coupled with the need for good health is expected to stimulate industry growth over the forecast period. The increasing incidence of gastrointestinal tract diseases, such as irritable bowel syndrome, constipation, inflammatory bowel disease, and gastroesophageal reflux disease, has raised concerns towards stomach health, which in turn is anticipated to fuel product growth.

Digestive enzyme supplements have to comply with various regulatory bodies including the U.S. Food and Drug Administration, Dietary Supplement Health and Education Act of 1994, and Natural Health Products Regulations for manufacturing and use. Increasing number of gymnasiums and fitness centers in emerging markets including China and India on account of rising awareness towards muscle improvement and reducing fat content among individuals will propel product demand.

Plant-based enzymes accounted for 41.3% of the overall revenue in 2015 and are expected to foresee considerable growth as these products aid in reducing acid indigestion, heartburn, reflux, and other digestive disturbances. Furthermore, the usability of these products across a wide range of pH levels is likely to expand their application.

Europe is expected to observe substantial revenue rise at a CAGR of 7.3% from 2016 to 2025. Easy availability of the product owing to the presence of a large number of supermarket chains along with increasing awareness regarding gastrointestinal problems is expected to fuel market size over the next nine years.

Central and South America is expected to foresee substantial growth owing to increasing prevalence of digestive disorders in the region. Increasing consumer awareness regarding the harm caused by the digestive system due to the lack of supplements and nutrients in the human body is anticipated to fuel expansion.

Companies Mentioned:

  • Klaire Laboratories
  • Enzymes, Inc.
  • ProteoZymes
  • National Enzyme Company
  • Enzymedica
  • AST Enzymes
  • VEMO 9OOD
  • Advanced Vital Enzymes Pvt. Ltd.
  • Zeus Biotech Limited
  • Vox Nutrition Inc.
  • Enzyme Bioscience Pvt. Ltd.
  • Metagenics
  • XYMOGEN Inc.
  • Douglas Laboratories
  • Thorne Research
  • Integrative Therapeutics, LLC
  • Pure Encapsulations
  • Ortho Molecular Products Inc.
  • Designs for Health Inc.
  • Master Supplements Inc.

Key Topics Covered:

1. Methodology and Scope

2. Executive Summary

3. Digestive Enzyme Supplements Market Variables, Trends & Scope

4. Digestive Enzyme Supplements Market: Origin Estimates & Trend Analysis

5. Digestive Enzyme Supplements Market: Application Estimates & Trend Analysis

6. Digestive Enzyme Supplements Market: Regional Estimates & Trend Analysis

7. Competitive Landscape

8. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/tx6dh4/digestive_enzyme

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/digestive-enzyme-supplements-market-to-reach-16-billion-by-2025---growing-consumer-awareness-regarding-the-severity-of-digestive-disorders---research-and-markets-300414622.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy
2. Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers
3. UCB Announces Crohns Disease Data to be Presented at Digestive Disease Week 2015
4. Ardelyx Presents Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients at Digestive Disease Week 2015
5. Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG
6. Digestive Enzyme Supplements Market Size Worth $1.6 Billion By 2025: Grand View Research, Inc.
7. For Multiple Sclerosis Treatment, Prescriber Base for Genzymes Aubagio Among U.S. Neurologists Has Increased Significantly at Six Months Post-launch, Compared to One and Three Months Post-launch
8. Research by ClinMet Scientific Founder and Colleagues Point to Enzyme that Restores Function in Diabetic Kidney Disease
9. CA BOTANA Introduces SEA ENZYME CALIFORNIA BOTANICAL HAIR SERUM
10. Two-Thirds of Surveyed U.S. Neurologists Have Prescribed Genzymes Aubagio to Their Multiple Sclerosis Patients at One Year Post-Launch
11. Protein Structural Defects Are Enablers and Stimulators of Enzyme Catalysis, Scientist Ariel Fernandez Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... , May 10, 2017 Global Health ... Latin America , published its 2017 ranking ... ranking is based on extensive data analysis from GHI,s ... largest hospitals database for the region. The GHI database covers ... , offering more than 130 data points for each institution ...
(Date:5/10/2017)... 2017 CSSi, the global leader in patient ... industry, is proud to announce the launch of its ... features both enriched content and a customized layout that ... company,s already well-established position as the top global patient ... many months of hard work, we are delighted to ...
(Date:5/9/2017)... 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... Property Office has granted Oramed a patent titled, ... The patent covers Oramed,s invention of an oral ... an incretin hormone that stimulates the secretion of ...
Breaking Medicine Technology:
(Date:5/23/2017)... ... , ... New England Journal Of Medicine Confirms Viability of Rory’s Regulations and ... Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt Rory’s Regulations ... today reported on a new study released on May 21, 2017 in the New ...
(Date:5/23/2017)... ... 2017 , ... The National Council on Strength and Fitness ... organization’s Certified Strength Coach credential has earned accreditation from the National Commission for ... competency of qualified candidates for jobs in the Strength and Conditioning profession. The ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... ... Facial Plastic and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce a ... in building collagen and elastin in their face, neck, and body through a ...
(Date:5/23/2017)... ... 23, 2017 , ... Drs. Allen Huang and Jeffrey Wang, ... Las Vegas, NV, and the importance of treating it immediately. They are now ... for peri-implantitis, with or without a referral. As experienced periodontists and implant specialists, ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... video chat as a standard feature on its secure clinical communication platform. The ... voice to video depending on the type and urgency of a situation. ...
Breaking Medicine News(10 mins):